The PGAP® is currently the most researched risk-targeted intervention designed to reduce disability associated with a wide range of debilitating health and mental health conditions.
The PGAP® is considered to be one of the most cost effective approaches for reducing disability and fostering return to work in individuals who suffer from a wide range of debilitating health and mental health conditions.
The PGAP® has been shown to be effective in facilitating return to work in individuals who have sustained musculoskeletal injuries, individuals with chronic low back pain and fibromyalgia, as well as individual with debilitating mental health conditions such as depression and post-traumatic stress disorder.
To date, over 6000 PGAP® providers have been trained in more than 10 countries. There are PGAP® providers in Canada, the United States, New Zealand, Australia, United Kingdom, France, Sweden, Germany, Ireland, England, South Africa, Nigeria and Denmark.